For: | Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15(48): 6017-6022 [PMID: 20027672 DOI: 10.3748/wjg.15.6017] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i48/6017.htm |
Number | Citing Articles |
1 |
Hitoshi Teranishi, Masafumi Hayashi, Ryoko Higa, Kenji Mori, Takashi Miyazawa, Jun Hino, Yuichiro Amano, Ryuichi Tozawa, Takanori Ida, Toshikatsu Hanada, Mikiya Miyazato, Reiko Hanada, Kenji Kangawa, Kazuwa Nakao. Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice. Peptides 2018; 99: 134 doi: 10.1016/j.peptides.2017.09.011
|
2 |
Fatima Ameer, Lisa Scandiuzzi, Shahida Hasnain, Hubert Kalbacher, Nousheen Zaidi. De novo lipogenesis in health and disease. Metabolism 2014; 63(7): 895 doi: 10.1016/j.metabol.2014.04.003
|
3 |
T.G. Berezna, O.B. Synoverska, N.M. Fomenko. Biliary sludge syndrome induced by cephalosporins in children: clinical and diagnostic markers, management. CHILD`S HEALTH 2023; 18(6): 453 doi: 10.22141/2224-0551.18.6.2023.1633
|
4 |
Telma Sakuno, Letícia Mary Tomita, Carolina Mywa Tomita, Isabela de Carlos Back Giuliano, Amanda Ibagy, Nilza Maria Medeiros Perin, Lisiane Schilling Poeta. Avaliação ultrassonográfica da gordura visceral e subcutânea em crianças obesas. Radiologia Brasileira 2014; 47(3): 149 doi: 10.1590/0100-3984.2013.1828
|
5 |
Xiu-lian Lin, Ya-ling Zeng, Jie Ning, Zhe Cao, Lan-lan Bu, Wen-Jing Liao, Zhi-min Zhang, Tan-jun Zhao, Rong-geng Fu, Xue-Feng Yang, Yong-zhen Gong, Li-Mei Lin, De-liang Cao, Cai-ping Zhang, Duan-fang Liao, Ya-Mei Li, Jian-Guo Zeng. Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02162-5
|
6 |
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obesity Facts 2016; 9(2): 65 doi: 10.1159/000443344
|
7 |
Mi Ra Lee, Hye Jin Yang, Kwang Il Park, Jin Yeul Ma. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Phytomedicine 2019; 55: 14 doi: 10.1016/j.phymed.2018.07.008
|
8 |
Ana Luz Tobaruela-Resola, José I. Riezu-Boj, Fermin I. Milagro, Paola Mogna-Pelaez, José I. Herrero, Mariana Elorz, Alberto Benito-Boillos, Josep A. Tur, J. Alfredo Martínez, Itziar Abete, M. Angeles Zulet. Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention. Nutrients 2024; 16(11): 1547 doi: 10.3390/nu16111547
|
9 |
Xiaoyun Cheng, Jun Yamauchi, Sojin Lee, Ting Zhang, Zhenwei Gong, Radhika Muzumdar, Shen Qu, H. Henry Dong. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. Journal of Biological Chemistry 2017; 292(9): 3692 doi: 10.1074/jbc.M116.765917
|
10 |
Gabriela Esteves LEGHI, Fernanda Aparecida DOMENICI, Helio VANNUCCHI. INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. Arquivos de Gastroenterologia 2015; 52(3): 228 doi: 10.1590/S0004-28032015000300014
|
11 |
Annalisa Crudele, Nadia Panera, Maria Rita Braghini, Clara Balsano, Anna Alisi. The pharmacological treatment of nonalcoholic fatty liver disease in children. Expert Review of Clinical Pharmacology 2020; 13(11): 1219 doi: 10.1080/17512433.2020.1829468
|
12 |
Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro. A 360-degree overview of paediatric NAFLD: Recent insights. Journal of Hepatology 2013; 58(6): 1218 doi: 10.1016/j.jhep.2012.12.003
|
13 |
Pietro Vajro, Claudia Mandato, Maria Rosaria Licenziati, Adriana Franzese, Dino Franco Vitale, Selvaggia Lenta, Maria Caropreso, Gianfranco Vallone, Rosaria Meli. Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity‐related Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2011; 52(6): 740 doi: 10.1097/MPG.0b013e31821f9b85
|
14 |
S.-C. Hung, S.-W. Lai, M.-C. Chen, P.-C. Li, K.-C. Lin. Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan. European Geriatric Medicine 2013; 4(2): 78 doi: 10.1016/j.eurger.2012.11.004
|
15 |
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial. Clinical and Experimental Pediatrics 2022; 65(6): 304 doi: 10.3345/cep.2021.00787
|
16 |
Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Nicola Santoro. Pediatric non-alcoholic fatty liver disease: New insights and future directions. World Journal of Hepatology 2014; 6(4): 217-225 doi: 10.4254/wjh.v6.i4.217
|
17 |
Nehal El-Koofy, Hanaa El-Karaksy, Wafaa El-Akel, Heba Helmy, Ghada Anwar, Rokaya El-Sayed, Ahmad El-Hennawy. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children. European Journal of Radiology 2012; 81(11): 3120 doi: 10.1016/j.ejrad.2012.06.020
|
18 |
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology 2016; 64(6): 1388 doi: 10.1016/j.jhep.2015.11.004
|
19 |
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 2016; 59(6): 1121 doi: 10.1007/s00125-016-3902-y
|
20 |
Hamdollah Iraji, Vazgen Minasian, Roya Kelishadi. Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions. Pediatric Gastroenterology, Hepatology & Nutrition 2021; 24(1): 54 doi: 10.5223/pghn.2021.24.1.54
|
21 |
Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller, Manuel Romero-Gómez. Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica. Gastroenterología y Hepatología 2018; 41(5): 328 doi: 10.1016/j.gastrohep.2017.12.003
|
22 |
Claudia Della Corte, Anna Alisi, Raffaele Iorio, Arianna Alterio, Valerio Nobili. Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 2011; 12(12): 1901 doi: 10.1517/14656566.2011.587123
|
23 |
Thomas Lange, Martin Buechert, Manfred W. Baumstark, Peter Deibert, Sarah Gerner, Henric Rydén, Jochen Seufert, Ulrike Korsten‐Reck. Value of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity. Journal of Magnetic Resonance Imaging 2015; 42(5): 1214 doi: 10.1002/jmri.24919
|
24 |
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt. MacSween's Pathology of the Liver. 2012; : 293 doi: 10.1016/B978-0-7020-3398-8.00006-4
|
25 |
Marialena Mouzaki, Johane P. Allard. The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2012; 46(6): 457 doi: 10.1097/MCG.0b013e31824cf51e
|
26 |
Aline de Piano, Marco T. de Mello, Priscila de L. Sanches, Patrícia L. da Silva, Raquel M.S. Campos, June Carnier, Flavia Corgosinho, Denis Foschini, Deborah L. Masquio, Lian Tock, Lila M. Oyama, Claudia Maria da Penha Oller do Nascimento, Sérgio Tufik, Ana R. Dâmaso. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. European Journal of Gastroenterology & Hepatology 2012; : 1 doi: 10.1097/MEG.0b013e32835793ac
|
27 |
Anna Alisi, Rita de Vito, Lidia Monti, Valerio Nobili. Liver fibrosis in paediatric liver diseases. Best Practice & Research Clinical Gastroenterology 2011; 25(2): 259 doi: 10.1016/j.bpg.2011.02.008
|
28 |
Yun Zhu, Cindy Wang, Scott A. Becker, Katie Hurst, Lourdes M. Nogueira, Victoria J. Findlay, E. Ramsay Camp. miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer. Molecular Therapy 2018; 26(3): 744 doi: 10.1016/j.ymthe.2017.12.023
|
29 |
Edoardo Farinelli, David Giampaoli, Anja Cenciarini, Ephraim Cercado, Alberto Verrotti. Valproic acid and nonalcoholic fatty liver disease: A possible association?. World Journal of Hepatology 2015; 7(9): 1251-1257 doi: 10.4254/wjh.v7.i9.1251
|
30 |
Abdul Sattar Arif Khammas, Hasyma Abu Hassan, Sarah Qahtan M. Salih, Hayati Kadir, Ramlah Mohamad Ibrahim, Nurul Nadiah Mohamad Nasir, Rozi Mahmud. Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. Porto Biomedical Journal 2019; 4(2): e31 doi: 10.1016/j.pbj.0000000000000031
|
31 |
Valerio Nobili, Pietro Vajro, Antal Dezsofi, Bjorn Fischler, Nedim Hadzic, Joerg Jahnel, Thierry Lamireau, Patrick McKiernan, Valerie McLin, Piotr Socha, Sarah Tizzard, Ulrich Baumann. Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(4): 550 doi: 10.1097/MPG.0000000000000715
|
32 |
Sarwa Darwish Murad, Herold J. Metselaar. The invasion of fatty liver disease in liver transplantation. Transplant International 2016; 29(4): 416 doi: 10.1111/tri.12707
|
33 |
Zarazuela Zolkipli, Mary Sherlock, William D. Biggar, Glenn Taylor, Jamie S. Hutchison, Arie Peliowski, Benjamin A. Alman, Simon C. Ling, Ingrid Tein. Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks. European Journal of Paediatric Neurology 2012; 16(5): 549 doi: 10.1016/j.ejpn.2012.01.004
|
34 |
Valerio Nobili, Christine Carter-Kent, Ariel E Feldstein. The role of lifestyle changes in the management of chronic liver disease. BMC Medicine 2011; 9(1) doi: 10.1186/1741-7015-9-70
|
35 |
Connie Lin, Carl B. Rountree, Sosamma Methratta, Salvatore LaRusso, Allen R. Kunselman, Adam J. Spanier. Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children. Environmental Research 2014; 132: 264 doi: 10.1016/j.envres.2014.04.005
|
36 |
L. K. Williams, J. Veitch, K. Ball. What helps children eat well? A qualitative exploration of resilience among disadvantaged families. Health Education Research 2011; 26(2): 296 doi: 10.1093/her/cyr004
|
37 |
Eun Young Park, Min Kyung Lim, Jin-Kyoung Oh, Heeyoun Cho, Mi Jin Bae, E. Hwa Yun, Dong-il Kim, Hai-Rim Shin, Anna Alisi. Independent and Supra-Additive Effects of Alcohol Consumption, Cigarette Smoking, and Metabolic Syndrome on the Elevation of Serum Liver Enzyme Levels. PLoS ONE 2013; 8(5): e63439 doi: 10.1371/journal.pone.0063439
|
38 |
Eric Dybbro, Miriam B. Vos, Rohit Kohli. Special Population. Clinics in Liver Disease 2023; 27(2): 471 doi: 10.1016/j.cld.2023.01.012
|
39 |
Katerina Karaivazoglou, Maria Kalogeropoulou, Stelios Assimakopoulos, Christos Triantos. Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease. Psychosomatics 2019; 60(1): 10 doi: 10.1016/j.psym.2018.09.001
|
40 |
A. Alisi, G. Bedogni, G. Baviera, V. Giorgio, E. Porro, C. Paris, P. Giammaria, L. Reali, F. Anania, V. Nobili. Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2014; 39(11): 1276 doi: 10.1111/apt.12758
|
41 |
Hafsa Younus, Amit Sharma, Rosa Miquel, Alberto Quaglia, Subba Rao Kanchustambam, Kirstin A Carswell, Ameet G. Patel. Bariatric Surgery in Cirrhotic Patients: Is It Safe?. Obesity Surgery 2020; 30(4): 1241 doi: 10.1007/s11695-019-04214-7
|
42 |
Jayanta Paul, Raj Vigna Venugopal, Lorance Peter, Shihaz Hussain, Kula Naresh Kumar Shetty, Mohit P Shetti. Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver disease. Gastroenterology Report 2018; 6(1): 49 doi: 10.1093/gastro/gox020
|
43 |
S Lipnowski, CMA LeBlanc. Healthy active living: Physical activity guidelines for children and adolescents. Paediatrics & Child Health 2012; 17(4): 209 doi: 10.1093/pch/17.4.209
|
44 |
Valerio Nobili, Anna Alisi, Giuliano Torre, Rita De Vito, Andrea Pietrobattista, Giuseppe Morino, Jean De ville De Goyet, Giorgio Bedogni, Massimo Pinzani. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Translational Research 2010; 156(4): 229 doi: 10.1016/j.trsl.2010.05.008
|
45 |
Jin-Kyung Cho, Hyun-Sik Kang, Jin-Hwan Yoon. Exercise Strategies for the Prevention and Treatment of Non-alcoholic Fatty Liver Disease. The Korean Journal of Obesity 2015; 24(4): 190 doi: 10.7570/kjo.2015.24.4.190
|
46 |
Peter Makovicky, Eva Tumova, Zdenek Volek, Pavol Makovicky, Ludmila Vodickova, Jana Slyskova, Miroslav Svoboda, Alexandra Rejhova, Pavel Vodicka, Gabriel Samasca, Alena Kralova, Melinda Nagy, Marta Mydlarova-Blascakova, Jana Poracova. Histopathological aspects of liver under variable food restriction: Has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?. Pathology - Research and Practice 2014; 210(12): 855 doi: 10.1016/j.prp.2014.08.007
|
47 |
Anna Alisi, Valerio Nobili. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments. Nutrition 2012; 28(7-8): 722 doi: 10.1016/j.nut.2011.11.017
|
48 |
Shreyas S. Vasanawala, Huanzhou Yu, Ann Shimakawa, Michael Jeng, Jean H. Brittain. Estimation of liver T*2 in transfusion‐related iron overload in patients with weighted least squares T*2 IDEAL. Magnetic Resonance in Medicine 2012; 67(1): 183 doi: 10.1002/mrm.22986
|
49 |
Jing Jiang, Hu Li, Mei Tang, Lei Lei, Hong-Ying Li, Biao Dong, Jian-Rui Li, Xue-Kai Wang, Han Sun, Jia-Yu Li, Jing-Chen Xu, Yue Gong, Jian-Dong Jiang, Zong-Gen Peng. Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. International Journal of Molecular Sciences 2024; 25(10): 5086 doi: 10.3390/ijms25105086
|
50 |
Nadia Panera, Daniela Gnani, Annalisa Crudele, Sara Ceccarelli, Valerio Nobili, Anna Alisi. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(41): 15079-15086 doi: 10.3748/wjg.v20.i41.15079
|
51 |
Vikrant Sood, Seema Alam, Aabha Nagral, Anshu Srivastava, Aniket Deshmukh, Ashish Bavdekar, Bhaswati C. Acharyya, S. M. Geetha, Girish Gupte, Ishitaa Bhatia, Kritika Tiwari, Lalit Bharadia, Malathi Sathiyasekaran, Prabhsaran Kaur, Rajeev Khanna, Rimjhim Shrivastava, Samriddhi Poyekar, Snehavardhan Pandey, Somashekara Hosaagrahara Ramakrishna, Upendra Kinjawadekar, Vibhor Borkar, Viswanathan M. Sivaramakrishnan, Rohit Kohli, John Matthai, Anil Dhawan. Practice Recommendations for Metabolic Dysfunction–Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN). Indian Pediatrics 2024; 61(10): 919 doi: 10.1007/s13312-024-3290-1
|
52 |
D. Fintini, A. Pietrobattista, G. Morino, G. Cafiero, A. Calzolari, A. Turchetta, C. Brufani, A. Alisi, U. Giordano, V. Nobili. Energy expenditure and insulin sensitivity evaluation in obese children affected by hepatosteatosis. Pediatric Obesity 2012; 7(2) doi: 10.1111/j.2047-6310.2011.00018.x
|
53 |
Sojin Lee, Cuiling Zhu, Jun Yamauchi, Ping Zhu, Xiaoyun Feng, Shen Qu, H. Henry Dong. Lipid Signaling and Metabolism. 2020; : 247 doi: 10.1016/B978-0-12-819404-1.00013-0
|
54 |
Steven Hardee, Raffaella A. Morotti. Pediatric Obesity and the Liver. Academic Forensic Pathology 2013; 3(1): 28 doi: 10.23907/2013.005
|
55 |
Qing Pang, Jing-Yao Zhang, Si-Dong Song, Kai Qu, Xin-Sen Xu, Su-Shun Liu, Chang Liu. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World Journal of Gastroenterology 2015; 21(5): 1650-1662 doi: 10.3748/wjg.v21.i5.1650
|
56 |
Mary Sugden, Mark Holness. Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/ profiling. Clinical Lipidology 2011; 6(4): 427 doi: 10.2217/clp.11.30
|
57 |
Jung‐Eun Park, Hyun Tae Kim, Sujin Lee, Ye‐Suk Lee, Ung‐Kyu Choi, Jeong Han Kang, Soo Young Choi, Tae‐Cheon Kang, Myung‐Sook Choi, Oh‐Shin Kwon. Differential expression of intermediate filaments in the process of developing hepatic steatosis. PROTEOMICS 2011; 11(14): 2777 doi: 10.1002/pmic.201000544
|
58 |
Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller, Manuel Romero-Gómez. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. Gastroenterología y Hepatología (English Edition) 2018; 41(5): 328 doi: 10.1016/j.gastre.2018.05.013
|
59 |
Shenglin Liu, Wang Shi, Guolin Li, Bo Jin, Yaqin Chen, Hui Hu, Li Liu, Fuxia Xie, Keke Chen, Dazhong Yin. Plasma reactive carbonyl species levels and risk of non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2011; 26(6): 1010 doi: 10.1111/j.1440-1746.2011.06672.x
|